Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside

Immune checkpoint inhibitors have transformed the landscape of oncological therapy, but at the price of a new array of immune related adverse events. Among these is β-cell failure, leading to checkpoint inhibitor-related autoimmune diabetes (CIADM) which entails substantial long-term morbidity. As o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Linda Wu, Venessa H. M. Tsang, Sarah C. Sasson, Alexander M. Menzies, Matteo S. Carlino, David A. Brown, Roderick Clifton-Bligh, Jenny E. Gunton
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-11-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	immune checkpoint inhibitor (ICI) diabetes mellitus type 1 diabetes immune related adverse events immunotherapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2021.764138/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!